XML 28 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows ( Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Cash flows from operating activities:    
Net income $ 34,341 $ 32,314
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 9,808 9,244
Amortization of deferred revenue (579) (221)
Amortization of deferred financing costs 730 730
Accretion of asset retirement obligations 131 124
Deferred income taxes 0 66
Loss on equity method investments 435 149
Gain on asset disposals (44) (18)
Unit-based compensation expense 233 194
Changes in assets and liabilities, net of acquisitions:    
Accounts receivable 17,832 (11,131)
Inventories and other current assets 1,580 6,291
Accounts payable and other current liabilities (2,113) 192
Accounts receivable/payable to related parties (5,331) 8,219
Non-current assets and liabilities, net 566 407
Net cash provided by operating activities 57,589 46,560
Cash flows from investing activities:    
Business combinations 0 400
Purchases of property, plant and equipment (2,975) (13,535)
Proceeds from sales of property, plant and equipment 175 1,183
Equity method investments (33,119) (14,789)
Net cash used in investing activities (35,919) (27,541)
Cash flows from financing activities:    
Proceeds from issuance of additional units to maintain 2% General Partner interest 14 31
Distributions to general partner (4,087) (1,574)
Distributions to common unitholders - public (11,591) (9,801)
Distributions to common unitholders - Delek (6,255) (2,911)
Distributions to subordinated unitholders - Delek (11,503) (12,479)
Distributions to Delek for acquisitions 0 (61,890)
Proceeds from revolving credit facility 157,850 203,514
Payments of revolving credit facility (146,900) (138,364)
Predecessor division equity contribution 0 115
Reimbursement of capital expenditures by Delek 802 2,603
Net cash used in financing activities (21,670) (20,756)
Net decrease in cash and cash equivalents 0 (1,737)
Cash and cash equivalents at the beginning of the period 0 1,861
Cash and cash equivalents at the end of the period 0 124
Cash paid during the period for:    
Interest 5,855 3,863
Income taxes 0 5
Non-cash investing activities:    
Equity method investments 0 3,832
Decreases in accrued capital expenditures (892) 0
Non-cash financing activities:    
Sponsor contribution of fixed assets $ 609 $ 418